Discover
SIGA
SIGA Technologies, Inc.
3.92
5 x 2.82
9 x 5.01
bid
ask
+
0.19
5.24%
12:04 PM
timesize
| Ytd | -35.92% | |
| 1y | -41.39% |
3.75
day range
3.94
3.56
52 week range
9.62
| Open | 3.75 | Prev Close | 3.72 | Low | 3.75 | High | 3.94 | Mkt Cap | 281.16M |
| Vol | 178.33K | Avg Vol | 561.52K | EPS | 0.28 | P/E | 14.00 | Forward P/E | 4.79 |
| Beta | 0.89 | Short Ratio | 6.64 | Inst. Own | 53.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 03-25 | Earning | 08-04 | 50-d Avg | 4.40 | 200-d Avg | 6.12 | 1yr Est | 0.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | 0 | 0.02 | N/A | N/A |
| 2024-08-01 | 2024-06 | 0 | 0.03 | N/A | N/A |
| 2024-05-07 | 2024-03 | 0 | 0.14 | N/A | N/A |
| 2024-03-12 | 2023-12 | 0 | 1.01 | N/A | N/A |
| 2023-11-07 | 2023-09 | 0 | -0.01 | N/A | N/A |
| 2023-08-08 | 2023-06 | 0 | -0.04 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2012-11-06 | Wedbush | Upgrade | Outperform |
Profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-10 | FORD HAROLD EUGENE JR | Director | 17.30K | Conversion of Exercise of derivative security |
| 2024-06-30 | HRUBY DENNIS E | Officer | 169.26K | Conversion of Exercise of derivative security |
| 2024-06-10 | KNISELY EVAN A | Director | 17.30K | Conversion of Exercise of derivative security |
| 2024-06-30 | LUCKSHIRE DANIEL J | Chief Financial Officer | 263.22K | Conversion of Exercise of derivative security |
| 2024-06-10 | MARSHALL JOSEPH W. III | Director | 216.28K | Conversion of Exercise of derivative security |
| 2024-06-10 | NABEL GARY J. | Director | 43.51K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Blackrock Inc. | 4.02M | 23.86M | 4.96% |
| 2024-09-29 | Vanguard Group Inc | 2.57M | 15.24M | 3.17% |
| 2024-09-29 | First Wilshire Securities Management Inc | 2.44M | 14.49M | 3.01% |
| 2024-09-29 | AltraVue Capital, LLC | 2.31M | 13.74M | 2.86% |
| 2024-09-29 | Hotchkis & Wiley Capital Management, LLC | 2.05M | 12.17M | 2.53% |
| 2024-09-29 | Dimensional Fund Advisors LP | 1.91M | 11.33M | 2.36% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 1.24M | 7.35M | 1.53% |
| 2024-10-30 | iShares Russell 2000 ETF | 1.21M | 7.16M | 1.49% |
| 2024-09-29 | Avantis U.S. Small Cap Value ETF | 959.87K | 5.70M | 1.19% |
| 2024-10-30 | American Beacon Small Cap Value Fd | 849.60K | 5.05M | 1.05% |
| 2024-09-29 | Hotchkis and Wiley Small Cap Value Fund | 759.60K | 4.51M | 0.94% |
| 2024-07-30 | Federated Hermes MDT Small Cap Core Fund | 746.29K | 4.43M | 0.92% |
Dividend
| Dividend | Date |
|---|---|
| 0.6 | 2026-04-07 |
| 0.6 | 2025-04-29 |
| 0.6 | 2024-03-25 |
| 0.45 | 2023-05-15 |
| 0.45 | 2022-05-16 |